Thu, October 19, 2023
Wed, October 18, 2023
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023

Anupam Rama Maintained (SNDX) at Buy with Increased Target to $38 on, Oct 17th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-38-on-oct-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Increased Target from $36 to $38 on, Oct 17th, 2023.

Anupam has made no other calls on SNDX in the last 4 months.



There are 9 other peers that have a rating on SNDX. Out of the 9 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Anupam


  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Wednesday, October 11th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Tuesday, October 3rd, 2023
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $42 on, Monday, October 2nd, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023